Related Experiment Video
Updated: Jan 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Shaping the Future of DHT Assessment: Insights on Industry Challenges, Developer Needs, and a Harmonized, European
Fruzsina Mezei1, Emmanouil Tsiasiotis1, Michele Basile1
1The Graduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, 00168 Rome, Italy; emmanouil.tsiasiotis@unicatt.it (E.T.); michele.basile@unicatt.it (M.B.); ilaria.sciomenta@altemsadvisory.it (I.S.); elenamaria.calosci@altemsadvisory.it (E.M.C.); debora.antonini@altemsadvisory.it (D.A.); rossella.dibidino@policlinicogemelli.it (R.D.B.); americo.cicchetti@unicatt.it (A.C.).
Abstract:
Introduction: Market access, pricing, and reimbursement of digital health technologies (DHTs) in Europe are significantly challenged by regulatory fragmentation and various assessment methodologies. Understanding the challenges and priorities of technology developers is essential for developing effective and relevant policy responses. This study explores perceived barriers and developer-driven priorities to inform the development of a harmonized health technology assessment (HTA) framework under the EDiHTA project. Methods: A mixed-methods approach was adopted, including a scoping review to identify key challenges, a survey of 20 DHT developers, and interviews and focus groups with 29 industry representatives from startups to multinational companies across 10 European countries during 2024. Results: Key challenges included a lack of transparency in reimbursement processes, fragmented HTA requirements, and misalignment between traditional evidence models and the agile development of DHTs. Developers highlighted the need to integrate real-world evidence, consider usability and implementation factors, and provide structured, lifecycle-based guidance. Financial barriers and procedural burdens were particularly significant for small and medium-sized enterprises. Conclusions: These findings highlight the need for an HTA framework that reflects the iterative nature of digital development, integrates real-world evidence, and reduces uncertainty for developers. The EDiHTA project aims to respond to these challenges by building a harmonized and flexible approach that aligns with the goals of the European HTA Regulation.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Preclinical Development: Overview

